HARVEY J. BERGER, MD, is ARIAD’s principal Founder and has served as
its Chairman of the Board, President and Chief Executive Officer since
April 1991. From 1986 to 1991, Dr. Berger held a series of senior
management positions at Centocor, Inc., a biotechnology company, most
recently as Executive Vice President and President of the Research and
Development Division. He also has held senior academic and
administrative appointments at Emory University, Yale University and the
University of Pennsylvania and was an Established Investigator of the
American Heart Association. Dr. Berger received his BA degree in Biology
from Colgate University, his MD degree from Yale University School of
Medicine and did further medical and research training at the
Massachusetts General Hospital and Yale-New Haven Hospital.
Harvey Berger - Ariad Pharmaceuticals Inc (aria)
May 29, 2000